CORT

NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks

$108.35

-2.34 (-2.11%)

CORT News1 articles

Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance

Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.

Earnings Jul 30